Category: Biosimilars
Global Biosimilars
-
NFC Market by Offering (NFC ICs, NFC Antennas, NFC Tags, NFC Readers), Operating Mode (Reader Emulation, Peer-to-Peer, Card Emulation), Use Cases (Payment and Transactions, Product Identification, Ticketing, Access Control) - Global Forecast to 2029
... global NFC market was valued at USD 21.69 billion in 2024 and is projected to reach USD 30.55 billion by 2029; it is expected to register a CAGR of 7.1% during the forecast period. NFC ... Read More
-
Erythropoietin Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global erythropoietin drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global erythropoietin ... Read More
-
Wireless Power Transmission Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.0% during 2025-2034. This report on global wireless power transmission market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Global Biotech Ingredients Market Size Study, by Type (Active Pharmaceutical Ingredients, Biosimilars), by Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), by Expression Systems (Mammalian, Microbial, Yeast, Plant, Insect), and Regional Forecasts 2022-2032
... Insect), and Regional Forecasts 2022-2032 Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to ... Read More
-
Global Rituximab Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Rituximab Biosimilars market. Rituximab Biosimilars ... Read More
-
Global Erythropoietin Stimulating Agents Market 2024-2028
... stimulating agents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Immunology Biosimilars Market (2024 Edition): Analysis By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... report titled “Global Immunology Biosimilars Market (2024 Edition)” which provides an analysis of the Global Immunology Biosimilars industry in terms of market segmentation By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel (Hospital ... Read More
-
Global Ranibizumab Drugs and Biosimilars Market Growth 2024-2030
... disease.Biosimilars of ranibizumab are biologic products that are highly similar to the original reference drug(ranibizumab)in terms of structure,efficacy,safety,and quality.These biosimilars aim to provide more affordable treatment options while maintaining therapeutic equivalence to the original biologic ... Read More
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
... Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029. Major pharmaceutical companies have ... Read More
-
Global G-CSF and G-CSF Biosimilars Market Growth 2024-2030
... downstream market, the G-CSF and G-CSF Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Biosimilars Treatment Market Growth (Status and Outlook) 2024-2030
... market, the Biosimilars Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilars Treatment ... Read More
-
Bioburden Testing
... growing at a CAGR of 9.8% over the period 2023-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record 10.2% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
... vital insights that can help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and ... Read More
-
Global Biosimilars Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Erythropoietin Drugs Market Report by Drug Class (Biologics, Biosimilars), Product Type (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, and Others), Application (Hematology, Kidney Disorder, Cancer, and Others), End-User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2024-2032
... erythropoietin drugs market size reached US$ 11.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The growing ... Read More
-
Global Biotechnology Contract Manufacturing Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... Region, and Segment Forecasts, 2023 – 2030 Global Biotechnology Contract Manufacturing Market was valued US$ 16.5 Billion in 2022 and is expected to reach ~US$ 36.5 Billion by 2032, growing at a CAGR of 8.3% ... Read More
-
Global Biosimilar Monoclonal Antibody Market Research Report 2024(Status and Outlook)
... produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic ... Read More
-
Biosimilars
... of 20.1% over the analysis period 2023-2030. Recombinant Non-glycosylated Proteins, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$62.4 Billion by the end of the analysis ... Read More
-
Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
... titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, ... Read More
-
2024 Global Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2024-2030
... 5.05 billion in 2023 and expected to reach USD 5.80 billion in 2024, at a CAGR 14.51% to reach USD 13.04 billion by 2030. The recombinant proteins are created by inserting a modified gene into ... Read More
-
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2024-2030
... 46.76 billion in 2024, at a CAGR 7.63% to reach USD 73.03 billion by 2030. The insulin market encompasses the production, distribution, and consumption of various insulin types used to treat diabetes mellitus, a chronic ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
Oncology Biosimilars Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Monoclonal Antibodies, G-CSF, Hematopoietic Agents, Others), By Type of Cancer (Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer, Cervical Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F
... Cancer, Blood Cancer, Brain Cancer, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F Global Oncology Biosimilars Market was valued at USD 3.27 Billion in 2023 and is anticipated ... Read More
Research Assistance
